PMC:7029759 / 22122-22406 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"512","span":{"begin":174,"end":183},"obj":"Species"},{"id":"516","span":{"begin":14,"end":18},"obj":"Disease"},{"id":"517","span":{"begin":89,"end":93},"obj":"Disease"},{"id":"518","span":{"begin":154,"end":163},"obj":"Disease"}],"attributes":[{"id":"A512","pred":"tao:has_database_id","subj":"512","obj":"Tax:2697049"},{"id":"A516","pred":"tao:has_database_id","subj":"516","obj":"MESH:D045169"},{"id":"A517","pred":"tao:has_database_id","subj":"517","obj":"MESH:D045169"},{"id":"A518","pred":"tao:has_database_id","subj":"518","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T327","span":{"begin":14,"end":18},"obj":"SP_10"},{"id":"T326","span":{"begin":66,"end":72},"obj":"UBERON:0002405;GO:0006955"},{"id":"T325","span":{"begin":73,"end":81},"obj":"GO:0006955"},{"id":"T324","span":{"begin":89,"end":93},"obj":"SP_10"},{"id":"T323","span":{"begin":174,"end":183},"obj":"SP_7"},{"id":"T322","span":{"begin":237,"end":243},"obj":"UBERON:0002405;GO:0006955"},{"id":"T321","span":{"begin":244,"end":252},"obj":"GO:0006955"},{"id":"T320","span":{"begin":262,"end":269},"obj":"NCBITaxon:10239"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T126","span":{"begin":37,"end":41},"obj":"Body_part"},{"id":"T127","span":{"begin":94,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma256135"},{"id":"A127","pred":"fma_id","subj":"T127","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T64","span":{"begin":14,"end":18},"obj":"Disease"},{"id":"T65","span":{"begin":89,"end":93},"obj":"Disease"},{"id":"T66","span":{"begin":154,"end":163},"obj":"Disease"}],"attributes":[{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T191","span":{"begin":262,"end":269},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T83","span":{"begin":94,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T14","span":{"begin":66,"end":81},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T15","span":{"begin":237,"end":252},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}

{"project":"LitCovid-sentences","denotations":[{"id":"T144","span":{"begin":0,"end":284},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop."}